1. Commentary: Lessons from the COVID-19 global health response to inform TB case finding.
- Author
-
Oga-Omenka C, Tseja-Akinrin A, Boffa J, Heitkamp P, Pai M, and Zarowsky C
- Subjects
- COVID-19 therapy, COVID-19 transmission, Humans, Pandemics, Pneumonia, Viral therapy, Pneumonia, Viral transmission, SARS-CoV-2, Tuberculosis therapy, Tuberculosis transmission, COVID-19 epidemiology, Communicable Disease Control organization & administration, Global Health, Health Services Accessibility, Pneumonia, Viral epidemiology, Tuberculosis epidemiology
- Abstract
The coronavirus disease 2019 (COVID-19) has emerged as a serious threat to global public health, demanding urgent action and causing unprecedented worldwide change in a short space of time. This disease has devastated economies, infringed on individual freedoms, and taken an unprecedented toll on healthcare systems worldwide. As of 1 April 2020, over a million cases of COVID-19 have been reported in 204 countries and territories, resulting in more than 51,000 deaths. Yet, against the backdrop of the COVID-19 pandemic, lies an older, insidious disease with a much greater mortality. Tuberculosis (TB) is the leading cause of death by a single infectious agent and remains a potent threat to millions of people around the world. We discuss the differences between the two pandemics at present, consider the potential impact of COVID-19 on TB case management, and explore the opportunities that the COVID-19 response presents for advancing TB prevention and control now and in future., (Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF